Asia-Pacific Clinical Nutrition Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The APAC Clinical Nutrition Market is Segmented by Route of Administration (Oral and Enteral and Parenteral), Application (Nutritional Support in Malnutrition, Nutritional Support in Metabolic Disorders, Nutritional Support in Gastrointestinal Diseases, Nutritional Support in Neurological Diseases, Nutritional Support in Cancer, Nutritional Support in Other Diseases), End-User (Pediatric and Adult), and Geography (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific). The report offers the value in USD million for the abovementioned segments.

Asia-Pacific Clinical Nutrition Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Asia-Pacific Clinical Nutrition Market Size

View Global Report
Asia Pacific Clinical Nutrition Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 7.10 %
Market Concentration Low

Major Players

Asia Pacific Clinical Nutrition Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia-Pacific Clinical Nutrition Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Asia-Pacific Clinical Nutrition Market Analysis

The Asia-Pacific Clinical Nutrition Market is expected to register a CAGR of 7.1% during the forecast period.

COVID-19 significantly impacted the market studied in the initial phase as the patients affected with COVID-19 required nutrition and a proper diet to maintain their quality of life. For instance, an article published by PubMed depicted that an effective strategy, along with proper nutrition to prevent and treat COVID-19, was anticipated to improve nutrition to strengthen the immune system. Vitamin D has been recommended to prevent COVID-19, and an intake of 250 μg/day has been shown to raise serum 25(OH)D concentrations above 40-60 ng/mL (100-150 nmol/L). Low vitamin D3 leads to an increase in anti-inflammatory and immunoregulating interleukin 10 (IL-10) cytokines. It reduces the frequency of Th17 cells, which, in turn, decreases IL-17 and proinflammatory cytokine tumor necrosis factor-alpha (TNFα) production, decreasing inflammatory effects in the host. Thus, vitamin D deficiency is often found in patients with COVID-19. The Japanese diet closely resembles a "nutrient-dense dietary pattern", and it includes a lot of elements that guard against COVID-19 infection. People have become more aware and conscious of their nutritional intake in the post-pandemic scenario, which is anticipated to drive market growth in the coming years.

The major factors attributing to the growth of the Asia-Pacific clinical nutrition market include an increase in the prevalence of metabolic disorders and neurological diseases, a rise in the geriatric population in the Asia Pacific Region, and high spending on healthcare. For instance, as per the IDF 2021 report, in India, the number of people with diabetes was 74,194.7. Furthermore, as per the same source, the total diabetes-related health expenditure in 2021 was USD 8,485.8 million.

Dietary therapy is critical for normal growth and development and to prevent acute complications. It prevents long-term complications of the given disorder. A failure to follow specific dietary treatment can lead to complications and even death in individuals with metabolic disorders. Nutrition therapy for patients with inherited metabolic disorders is lifelong. The management of patients with many inborn errors of metabolism requires a multidisciplinary approach that combines both nutrition and medical management. In these disorders, nutrition therapy is a critical component of the management to prevent acute complications, such as metabolic decompensation, and to prevent long-term complications of the given disorder.

Vitamin D deficiency is one of the major crises faced by many people and is likely to cause serious illness. The presence of competitors, mergers, acquisitions, and product launches is anticipated to boost market growth as these activities increase the availability of products and raise competition. For instance, in March 2021, Royal DSM, a purpose-led global science-based company in nutrition, health, and sustainable living, launched ampli-D, a fast-acting form of vitamin D for dietary supplements in Australia. The availability of DSM's ampli-D in Australia, the first market for its launch, follows regulatory approval by TGA for its use in dietary supplements that do not require a doctor's prescription.

Most metabolic syndromes result in situations where the body lacks the capability to synthesize non-essential molecules, like vitamins and amino acids, and several molecules involved in metabolic pathways. Most of these conditions can be managed only with the supplementation of one or two nutrients. All these factors are anticipated to boost the market growth. However, there are a few factors that may restrain market growth, such as the heterogeneous nature of government coverage/reimbursement across countries.

Asia-Pacific Clinical Nutrition Industry Overview

The Asia-Pacific clinical nutrition market is highly fragmented and competitive, with several major players operating in the Asia-Pacific region. In terms of market share, a few major players dominate the clinical nutrition market. Additionally, a few more players are expected to enter the market in the coming years. Some of the key players are Abbott Nutrition, Nestle Health Science, Baxter Healthcare, B. Braun Melsungen AG, and Nutricia.

Asia-Pacific Clinical Nutrition Market Leaders

  1. B. Braun Melsungen AG

  2. Nutricia

  3. Abbott

  4. Nestlé

  5. Baxter

  6. *Disclaimer: Major Players sorted in no particular order
APAC Medical Clinical Nutrition Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Asia-Pacific Clinical Nutrition Market News

  • September 2022: H&H Group-owned Swisse, Australia's leading health, wellness, and beauty nutrition company, launched three new products in India, namely SwisseMe Melatonin Gummies, Biotin Gummies, and Plant Protein Powder.
  • July 2022: Nestle launched China's first Foods for Special Medical Purpose (FSMP) for patients suffering from tumor-related conditions after going through a five-year-long approval process from the Chinese regulator.

Asia-Pacific Clinical Nutrition Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Metabolic Disorders
    • 4.2.2 Increase in Geriatric Population in the Asia-Pacific Region
    • 4.2.3 High Spending on Healthcare Along with Rise of Middle-class in Emerging Economies
  • 4.3 Market Restraints
    • 4.3.1 Unwillingness of Hospitals and In-house Pharmacies/Dispensaries to Maintain the Required Stock of Clinical Nutrition Products
    • 4.3.2 Heterogeneous Nature Of Government Coverage/Reimbursement Across Countries
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Route of Administration
    • 5.1.1 Oral and Enteral
    • 5.1.2 Parenteral
  • 5.2 By Application
    • 5.2.1 Nutritional Support in Malnutrition
    • 5.2.2 Nutritional Support in Metabolic Disorders
    • 5.2.3 Nutritional Support in Gastrointestinal Diseases
    • 5.2.4 Nutritional Support in Neurological Diseases
    • 5.2.5 Nutritional Support in Cancer
    • 5.2.6 Nutritional Support in Other Diseases
  • 5.3 By End User
    • 5.3.1 Pediatric
    • 5.3.2 Adult
  • 5.4 Geography
    • 5.4.1 China
    • 5.4.2 Japan
    • 5.4.3 India
    • 5.4.4 Australia
    • 5.4.5 South Korea
    • 5.4.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Nestlé
    • 6.1.3 Baxter
    • 6.1.4 B. Braun Melsungen AG
    • 6.1.5 Nutricia
    • 6.1.6 Mead Johnson
    • 6.1.7 Perrigo Company PLC
    • 6.1.8 Fresenius Kabi
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Asia-Pacific Clinical Nutrition Industry Segmentation

As per the scope of the report, clinical nutrition is an area of medicine that offers treatment of medical disorders caused due to an improper diet or due to the body's inability to absorb the nutrients available in a normal diet. These clinical nutrition products are aimed at treating metabolic disorders, eating or nutritional disorders, and other disorders.

The Asia-Pacific clinical nutrition market is segmented by route of administration (oral and enteral and parenteral), application (nutritional support in malnutrition, nutritional support in metabolic disorders, nutritional support in gastrointestinal diseases, nutritional support in neurological diseases, nutritional support in cancer, and nutritional support in other diseases), end-user (pediatric and adult), and geography (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific). The report offers values in USD million for the abovementioned segments.

By Route of Administration Oral and Enteral
Parenteral
By Application Nutritional Support in Malnutrition
Nutritional Support in Metabolic Disorders
Nutritional Support in Gastrointestinal Diseases
Nutritional Support in Neurological Diseases
Nutritional Support in Cancer
Nutritional Support in Other Diseases
By End User Pediatric
Adult
Geography China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Need A Different Region or Segment?
Customize Now

Asia-Pacific Clinical Nutrition Market Research FAQs

What is the current Asia-Pacific Clinical Nutrition Market size?

The Asia-Pacific Clinical Nutrition Market is projected to register a CAGR of 7.1% during the forecast period (2025-2030)

Who are the key players in Asia-Pacific Clinical Nutrition Market?

B. Braun Melsungen AG, Nutricia, Abbott, Nestlé and Baxter are the major companies operating in the Asia-Pacific Clinical Nutrition Market.

What years does this Asia-Pacific Clinical Nutrition Market cover?

The report covers the Asia-Pacific Clinical Nutrition Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Clinical Nutrition Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Asia-Pacific Clinical Nutrition Industry Report

Statistics for the 2025 Asia-Pacific Clinical Nutrition market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Clinical Nutrition analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.